This page contains a Flash digital edition of a book.
» CHROMATOGRAPHY


»


[10], a screening process of candidate columns can be employed. An apparatus for automated coupling of analytical columns SFC system by Welch et al. [11] has been described for coupling of chiral column pairs. A similar setup for coupled chiral-achiral screening can likewise be employed. A suitable pre-purifi cation analysis resulting from this arrangement can lead to a single step isolation of enantiomers from achiral impurities in a coupled column preparative step.


Results and Discussion


Achiral Column Set Selection Experiment A general gradient analysis performed with an analytical SFC/ MS system on eight achiral stationary phases was used to plot the retention data of a set of 70 diverse pharmaceutical compounds on a standard test plate. The phases tested were Silica, HILIC (cross-linked Diol), Nitro, DEAP (diethylaminopropyl), Pyridyl Amide, Imidazole, 4-Ethylpyridine and 2-Ethylpyridine, all 4.6 x 100 mm, 5 micron. The linear gradient program used for this achiral column evaluation was: 5 – 60% modifi er (methanol with 20mM NH3) in 3 min., held at 60% for 0.67 min., lowered to 5% over 0.33 min., and held for re-equilibration at 5% for 1 min. The columns were installed in various combinations on a software controlled 6-channel column selector on board an external autosampler for this experiment (see Figure 1). The SFC system outlet pressure was fi xed at 100 bar, column temperature 400C, and total fl ow rate was 4.0 mL/min.


Assembling all retention times from the 70 compounds yields a frequency distribution used for comparison of the various achiral phases tested. Shown in Figure 2 is the distribution found for six of the columns studied. (Two of the other phases tested had many cases of standards not eluting, 15 in the case of Nitro, four for DEAP. These were deemed unsuitable for the application and are not represented in this fi gure.) Ideal properties for columns to be included in a general screening set are diff erences among compounds’ retention from


Figure 2. Histograms of retention times obtained from SFC gradient analysis of 70 diverse standard pharmaceutical compounds on each of six achiral columns arranged in 0.5-minute wide bins.


other columns in the set, relatively few cases of over-retention, tR 4 min. with this gradient, and a limited number under-retained, tR


> <


2 min. These properties increase the likelihood of fi nding alternative selectivity among the columns for arbitrary compounds to be encountered in the future.


In Figure 2, the histogram for the 2-ethylpyridine column “2-EP” exhibits overall shorter retention for the set shifting the retention distribution signifi cantly to the left compared with those of other phases. Although 2-ethylpyridine is one of the most widely used for achiral SFC, this data deems it a poor choice to include in an achiral screening set since it implies that two random compounds are more likely to have similar retention. The column is thus less likely to produce the added selectivity one may need in a complementary separation for this application.


exhibited the most similarity among specifi c compound retentions in the study, Pyridyl Amide was chosen to be kept in a fi nal four-column screening set (Silica, HILIC, Imidazole and Pyridyl Amide) as 4-EP added the least diversity to the group.


Coupling Diff erent Achiral Phases with One CSP


Having determined this set of achiral columns, each can be screened by coupling with the chiral column and mobile phase suitable for the racemate separation.


For example, if a good chiral separation


Figure 1. Coupled column system diagram. Flow through each of two column channels in series is possible with this fl exible setup on the SFC/MS analytical system. Bypass lines


are included in each column switching valve to allow for single column analyses as needed.


was achieved with 20% methanol modifi er on CSP #1, then achiral columns 1, 2, 3 and 4 would be individually coupled with that CSP and run sequentially with the 20% isocratic method, simply doubling the analysis time. The data from each of the four coupled methods would be compared to fi nd the most favorable separation conditions accounting for both resolution of the impurity from enantiomer peaks as well as peak shapes resulting from the two-column separation.


To illustrate the case of a chiral separation with an interfering achiral impurity, a racemate, Chlormezanone, was spiked with Chrysin and


92 | | September/October 2013 - 15TH ANNIVERSARY ISSUE


Since Pyridyl Amide and 4-ethylpyridine “4-EP”


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156